Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Anichini

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|February 20, 1991
Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteinsR Mortarini, A Anichini, G Parmiani
Human Immunology|November 1, 1983
Clonal analysis of T lymphocyte response to an isolated class I disparityN Reinsmoen, A Anichini, F H Bach
Cancer Research|November 24, 2001
Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cellsG Pietra, R Mortarini, G Parmiani, et al.
International Journal of Cancer|February 15, 1990
Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinationsR Mortarini, F Belli, G Parmiani, et al.
Melanoma Research|July 1, 1992
Can oncogene (RAS) activation predict susceptibility of human melanoma to activated lymphocytes and, therefore, the clinical response of such neoplasms to adoptive immunotherapy?G Parmiani, A Anichini, G Carbone, et al.
International Journal of Cancer|October 15, 1986
Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gammaA Anichini, R Mortarini, G Fossati, et al.
International Journal of Cancer|September 15, 1990
Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive abilityA Anichini, R Mortarini, R Supino, et al.
Human Immunology|June 1, 1990
Multiple VLA antigens on a subset of melanoma clonesA Anichini, R Mortarini, E Berti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1989
Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interactionA Anichini, A Mazzocchi, G Fossati, et al.
Melanoma Research|August 1, 1991
An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysisA Mazzocchi, M Rodolfo, G Parmiani, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|February 20, 1991
Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteinsR Mortarini, A Anichini, G Parmiani
Human Immunology|November 1, 1983
Clonal analysis of T lymphocyte response to an isolated class I disparityN Reinsmoen, A Anichini, F H Bach
Cancer Research|November 24, 2001
Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cellsG Pietra, R Mortarini, G Parmiani, et al.
International Journal of Cancer|February 15, 1990
Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinationsR Mortarini, F Belli, G Parmiani, et al.
Melanoma Research|July 1, 1992
Can oncogene (RAS) activation predict susceptibility of human melanoma to activated lymphocytes and, therefore, the clinical response of such neoplasms to adoptive immunotherapy?G Parmiani, A Anichini, G Carbone, et al.
International Journal of Cancer|October 15, 1986
Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gammaA Anichini, R Mortarini, G Fossati, et al.
International Journal of Cancer|September 15, 1990
Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive abilityA Anichini, R Mortarini, R Supino, et al.
Human Immunology|June 1, 1990
Multiple VLA antigens on a subset of melanoma clonesA Anichini, R Mortarini, E Berti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1989
Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interactionA Anichini, A Mazzocchi, G Fossati, et al.
Melanoma Research|August 1, 1991
An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysisA Mazzocchi, M Rodolfo, G Parmiani, et al.
Pageof 9